The increasing genetic diversity of HIV-1 in the UK, 2002-2010
- PMID: 24257094
- PMCID: PMC3940288
- DOI: 10.1097/QAD.0000000000000119
The increasing genetic diversity of HIV-1 in the UK, 2002-2010
Abstract
Objective: HIV-1 is typically categorized by genetically distinct viral subtypes. Viral subtypes are usually compartmentalized by ethnicity and transmission group and, thus, convey important epidemiological information, as well as possibly influencing the rate of disease progression. We aim to describe the prevalence and time trends of subtypes observed among key populations living with HIV-1 in the UK.
Design: Analyses of reverse transcriptase and protease sequences generated from HIV-1-positive antiretroviral-naive patients as part of routine resistance testing between 2002 and 2010 in all public health and NHS laboratories in the UK.
Methods: Subtype was assigned centrally using the SCUEAL algorithm. Subtyping results were combined with data from the UK Collaborative HIV Cohort Study and the UK HIV and AIDS Reporting System. Analyses adjusted for the number of national HIV-1 diagnoses made each year within demographic subgroups. Viral subtypes were described overall, over time and by demographic subgroup.
Results: Subtype B diagnoses (39.9%) have remained stable since 2005, whereas subtype C diagnoses (34.3%) were found to decline in prevalence from 2004. Across most demographic subgroups, the prevalence of non-B non-C subtypes has increased over time, in particular novel recombinant forms (9.9%), subtype G (2.7%), and CRF01 AE (2.0%).
Conclusion: HIV-1 subtypes are increasingly represented across all demographic subgroups and this could be evidence of sexual mixing. Between 2002 and 2010, the prevalence of novel recombinant forms has increased in all demographic subgroups. This increasing genetic diversity and the effect of subtype on disease progression may impact future HIV-1 treatment and prevention.
Figures
Similar articles
-
Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000-2014.AIDS Res Hum Retroviruses. 2016 Mar;32(3):211-9. doi: 10.1089/AID.2015.0206. Epub 2015 Dec 1. AIDS Res Hum Retroviruses. 2016. PMID: 26530340
-
Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy.PLoS One. 2013;8(3):e57789. doi: 10.1371/journal.pone.0057789. Epub 2013 Mar 1. PLoS One. 2013. PMID: 23469241 Free PMC article.
-
Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.Virol J. 2011 Aug 26;8:416. doi: 10.1186/1743-422X-8-416. Virol J. 2011. PMID: 21871090 Free PMC article.
-
Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis.Lancet Infect Dis. 2019 Feb;19(2):143-155. doi: 10.1016/S1473-3099(18)30647-9. Epub 2018 Nov 30. Lancet Infect Dis. 2019. PMID: 30509777
-
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.AIDS Rev. 2003 Jan-Mar;5(1):25-35. AIDS Rev. 2003. PMID: 12875105 Review.
Cited by
-
HIV incidence among sexual health clinic attendees in England: First estimates for black African heterosexuals using a biomarker, 2009-2013.PLoS One. 2018 Jun 20;13(6):e0197939. doi: 10.1371/journal.pone.0197939. eCollection 2018. PLoS One. 2018. PMID: 29924799 Free PMC article.
-
A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project.PLoS One. 2018 Feb 1;13(2):e0192081. doi: 10.1371/journal.pone.0192081. eCollection 2018. PLoS One. 2018. PMID: 29389981 Free PMC article.
-
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.Cell Host Microbe. 2021 Jul 14;29(7):1093-1110. doi: 10.1016/j.chom.2021.05.012. Epub 2021 Jun 3. Cell Host Microbe. 2021. PMID: 34242582 Free PMC article. Review.
-
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.J Infect Dis. 2016 Nov 1;214(9):1302-1308. doi: 10.1093/infdis/jiw213. Epub 2016 May 24. J Infect Dis. 2016. PMID: 27732929 Free PMC article.
-
A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland.Sci Rep. 2016 Sep 19;6:32251. doi: 10.1038/srep32251. Sci Rep. 2016. PMID: 27642070 Free PMC article.
References
-
- Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, et al. HIV-1 nomenclature proposal. Science 2000; 288:55–56 - PubMed
-
- Los Alamos National Laboratory HIV Circulating Recombinant Forms (CRFs). http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html [Accessed 28 August 2013]
-
- Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, et al. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis 2009; 48:1296–1305 - PubMed
-
- Holguin A, Ramirez de Arellano E, Rivas P, Soriano V. Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes. AIDS Rev 2006; 8:98–107 - PubMed
-
- Pai NP, Shivkumar S, Cajas JM. Does genetic diversity of HIV-1 non-B subtypes differentially impact disease progression in treatment-naive HIV-1-infected individuals? A systematic review of evidence: 1996–2010. JAIDS 2012; 59:382–388 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical